Activ Surgical’s Platform Technology Strives To Be The ‘Waze’ Intra-Operative Navigation System For Surgeons
The company plans to make ActivSight and ActivInsights commercially available in 2023
Executive Summary
Activ Surgical’s CEO Todd Usen sat down with Medtech Insight to discuss the company’s product portfolio – ActivSight, an imaging module technology and ActivInsights, which uses artificial intelligence and machine learning to produce further clinical insights based on surgical data.
You may also be interested in...
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.